Hasil Pencarian - Rodney H. Falk

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Evaluating Prognosis in AL Amyloidosis

    Evaluating Prognosis in AL Amyloidosis oleh Rodney H. Falk, MD, Vasvi Singh, MD, Sharmila Dorbala, MD

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone

    Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone oleh Jessica Laird, BA, Rodney H. Falk, MD, Melissa Coyle, PharmD, CSP, Sarah A.M. Cuddy, MB BCH, BAO

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis

    True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis oleh Avinainder Singh, Hallie I. Geller, Kevin M. Alexander, Robert F. Padera, Richard N. Mitchell, Sharmila Dorbala, Jorge J. Castillo, Rodney H. Falk

    Diterbitkan 2018-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain‐mediated cardiotoxicity

    Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain‐mediated cardiotoxicity oleh Jian Guan, Shikha Mishra, Yiling Qiu, Jianru Shi, Kyle Trudeau, Guy Las, Marc Liesa, Orian S Shirihai, Lawreen H Connors, David C Seldin, Rodney H Falk, Calum A MacRae, Ronglih Liao

    Diterbitkan 2015-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study

    Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an... oleh Ashutosh Wechalekar, Gunnar Antoni, Wasfi Al Azzam, Mats Bergström, Swethajit Biswas, Chao Chen, Joseph Cheriyan, Matthew Cleveland, Louise Cookson, Paul Galette, Robert L. Janiczek, Raymond Y. Kwong, Mary Ann Lukas, Helen Millns, Duncan Richards, Ian Schneider, Scott D. Solomon, Jens Sörensen, James Storey, Douglas Thompson, Guus van Dongen, Danielle J. Vugts, Anders Wall, Gerhard Wikström, Rodney H. Falk

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI study

    Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI study oleh Ethan Katznelson, Michael Jerosch-Herold, Sarah A. M. Cuddy, Sarah A. M. Cuddy, Olivier F. Clerc, Olivier F. Clerc, Dominik C. Benz, Alexandra Taylor, Alexandra Taylor, Shivani Rao, Shivani Rao, Marie Foley Kijewski, Ronglih Liao, Heather Landau, Andrew J. Yee, Frederick L. Ruberg, Marcelo F. Di Carli, Marcelo F. Di Carli, Rodney H. Falk, Raymond Y. Kwong, Sharmila Dorbala, Sharmila Dorbala, Sharmila Dorbala

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: